British High Commissioner to India Philip Barton said the Oxford vaccine will be manufactured in India & that really ‘illustrates our partnership in the health sector’.
The assessment came despite the Oxford vaccine effort showing promising results in early human testing and is a sign of ongoing uncertainty over the likelihood of quick success.
Results from phase 1 of the Oxford-AstraZeneca trial were promising, but analysts remain concerned about whether it can match its competitors Pfizer-BioNtech & Moderna.
Oxford vaccine is under Phase II/III trials in multiple countries, where many have been given the vaccine & are being followed up with — a process that consumes time, but is standard.
Around 273 million people were lifted out of multidimensional poverty in India, the study by Oxford Poverty & Human Development Initiative with United Nations Development Programme has noted.
The anti-malarial drug HCQ was left out of the WHO Solidarity trial and the USFDA emergency use list this week. Doctors in India say they don’t see any major side-effects from its use.
Dexamethasone is the first drug to be shown to improve survival in Covid patients. It reduced deaths by one-third in ventilated patients, an Oxford study stated.
Data shows re-alignment in India’s exports, with Tamil Nadu & Telangana posting strong growth in 2024-25 as traditional heavyweights Gujarat & Maharashtra see declines. Gujarat still leads, though.
Of the total package, $649 million will be utilised for additional hardware, software, and support services, and the remaining for Major Defence Equipment (MDE).
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS